Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 5/20 | 0.39 |
| ▸ | MMP3 | P08254 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL831494 | 0.91 | L3MBTL1 (0.43) | GAAALDH1A1MAPTLMNAL3MBTL1 | |
| SCHEMBL9964594 | 0.87 | GAA (0.38) | GAASMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL16262350 | 0.87 | GAA (0.46) | GAAMAPTLMNAL3MBTL1KMT2A | |
| SCHEMBL13624641 | 0.84 | ADRB2 (0.44) | GAASMN1; SMN2ALDH1A1MAPTL3MBTL1 | |
| SCHEMBL16573653 | 0.84 | GAA (0.40) | GAASMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL830138 | 0.84 | L3MBTL1 (0.41) | GAASMN1; SMN2MAPTPPARALMNA | |
| SCHEMBL12810621 | 0.83 | GAA (0.38) | GAAMAPTLMNAL3MBTL1KMT2A | |
| SCHEMBL9964595 | 0.82 | L3MBTL1 (0.37) | GAASMN1; SMN2MAPTLMNAL3MBTL1 | |
| SCHEMBL16262351 | 0.81 | L3MBTL1 (0.41) | GAAALDH1A1MAPTLMNAL3MBTL1 | |
| SCHEMBL9967374 | 0.81 | L3MBTL1 (0.49) | GAASMN1; SMN2ALDH1A1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143325-B2 | Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices | BEZWADA BIOMEDICAL, LLC (US) | 2012-03-27 | — | — | US | disclosed |
| US-20100260702-A1 | BIOABSORBABLE AND BIOCOMPATIBLE POLYURETHANES AND POLYAMIDES FOR MEDICAL DEVICES | BEZWADA BIOMEDICAL LLC (US) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100260702-A1 | BIOABSORBABLE AND BIOCOMPATIBLE POLYURETHANES AND POLYAMIDES FOR MEDICAL DEVICES | ALOX12, HAO2, ALOX15 | GAA 1766/4885SMN1; SMN2 1816/4885ALDH1A1 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.